Status:
COMPLETED
Role of High Mobility Group Box 1 as a Prognostic Biomarker in Patients Undergoing Off-pump Coronary Artery Bypass Graft
Lead Sponsor:
Yonsei University
Conditions:
Coronary Artery Occlusive Disease
Eligibility:
All Genders
20+ years
Brief Summary
High mobility group 1 (HMGB1) protein is both a nuclear factor and a secreted protein, and has recently been identified as a cytokine mediator of systemic inflammation. HMGB1 is released by inflammato...
Eligibility Criteria
Inclusion
- Age ≥ 20
- Patients undergoing off-pump coronary artery bypass graft
Exclusion
- Age \< 20
- Patients undergoing off-pump coronary artery bypass graft with other simultaneous surgery
- Patients participating other study
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 16 2017
Estimated Enrollment :
255 Patients enrolled
Trial Details
Trial ID
NCT02206412
Start Date
July 1 2014
End Date
March 16 2017
Last Update
June 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology & Pain Medicine, Yonsei university college of medicine
Seoul, South Korea, 120-752